Series of reviews discuss key issues in chronic kidney disease and bone disorders

Metabolic bone disease is a common complication of chronic kidney disease (CKD) and involves a broad spectrum of disorders of mineral metabolism that result in both skeletal and extra-skeletal consequences.

A new special issue of Calcified Tissue International brings together a comprehensive series of state-of-the-art reviews which discuss key issues in CKD and mineral and bone disorders, known as CKD-MBD. Authored by a multidisciplinary group of leading international experts, the wide-ranging reviews aim to improve the understanding and management of CKD-MBD, and advance interdisciplinary knowledge.

Professors René Rizzoli and Stuart Ralston, Editors of Calcified Tissue International, stated:

"We greatly thank the authors for their contributions and the guest editors Professors J. B Cannata-Andía, N. Carrillo-López, and A. Ferreira, for curating this excellent series of reviews. The special issue brings together multidisciplinary expertise and covers many key topics of great importance to the field. We hope that these contributions will help to foster interaction among the diverse specializations involved in CKD-MBD research and clinical management."

Journal reference:

Cannata-Andía, J., et al. (2021) Bone in CKD, a Fascinating Evolving Topic. Calcified Tissue International.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Wistar scientists develop Persistent Multivalent T Cell Engager for advanced kidney cancer